These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 274165)

  • 21. [Immunotherapy of acute leukemias--present status and perspectives].
    Kvasnicka J
    Vnitr Lek; 1980 Apr; 26(4):209-17. PubMed ID: 6930131
    [No Abstract]   [Full Text] [Related]  

  • 22. [Our experience in using chemo- and immunotherapy for children with acute leukemia].
    Blau HI; Schultz M
    Probl Gematol Pereliv Krovi; 1981 Aug; 26(8):25-6. PubMed ID: 6946412
    [No Abstract]   [Full Text] [Related]  

  • 23. The HLA system in acute leukaemia and Hodgkin's disease.
    Harris R; Lawler SD; Oliver RT
    Br Med Bull; 1978 Sep; 34(3):301-4. PubMed ID: 363226
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunotherapy of acute infantile leukemia].
    De Bernardi B; Zanesco L; Carli M
    Minerva Med; 1972 Mar; 63(24):1468-70. PubMed ID: 4502510
    [No Abstract]   [Full Text] [Related]  

  • 25. Preliminary report: trials on the use of BCG vaccine as adjuvant immunotherapeutic agent in treatment of acute lymphoblastic leukemia in Egypt.
    Sakr R; Imam ZE; Samuel S; Sourial S; Habib A; Morsy S; Nour S
    J Egypt Public Health Assoc; 1980; 55(1-2):89-96. PubMed ID: 7042888
    [No Abstract]   [Full Text] [Related]  

  • 26. [Administration of BCG-CWS for the treatment of leukemia in children.--Management of acute leukemia after cessation of maintenance chemotherapy-- (author's transl)].
    Ha K; Tawa A; Shu K; Ikeda T; Yabuuchi H; Nishida M
    Rinsho Ketsueki; 1980 Jun; 21(6):759-67. PubMed ID: 6936563
    [No Abstract]   [Full Text] [Related]  

  • 27. BCG as active immunotherapy in children with acute lymphoblastic leukemia in longstanding remission: positive effects on remission duration and immunologic parameters.
    Miale TD; Yocum D; Yocum C
    Biomedicine; 1978 May; 28(2):96-104. PubMed ID: 276382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune complexes in children with leukemia: relationship to disease characteristics and to antibody response to Mycobacterium bovis (BCG) in patients receiving BCG immunotherapy.
    Minden P; Odom LF; Tubergen DG; Hardtke MA; Sharpton TR; Rose B; Zlotnick A; Carr RI
    Cancer; 1980 Feb; 45(3):460-8. PubMed ID: 6986198
    [No Abstract]   [Full Text] [Related]  

  • 29. Letter: Stimulation of K cells by immunotherapy.
    Campbell AC; MacLennan IC
    Lancet; 1976 Apr; 1(7964):856-7. PubMed ID: 56669
    [No Abstract]   [Full Text] [Related]  

  • 30. [Acute lymphoblastic and nonlymphoblastic leukemia in 1st complete remission: consolidation treatment by intensive radio-chemotherapy followed by transplantation of HLA-A, B and Dr compatible allogeneic bone marrow].
    Gyger M; Perreault C; Bonny Y; Bélanger R; David M; Boileau J; Tawil E; Lavallée R; Lacombe M; d'Angelo G
    Union Med Can; 1986 Oct; 115(10):699-702. PubMed ID: 3541340
    [No Abstract]   [Full Text] [Related]  

  • 31. Chemoimmunotherapy of acute leukemia in children.
    Bergolz VM; Kisljak NS; Eremeev VS; Rumjanzev AG; Akimova GV; Molochkina AM; Osipov SG
    Neoplasma; 1978; 25(3):359-63. PubMed ID: 277786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-A9 and survival in acute lymphocytic leukemia and myelocytic leukemia.
    Cohen E; Singal DP; Khurana U; Gregory SG; Cox C; Sinks L; Henderson E; Fitzpatrick JE; Higby D
    Prog Clin Biol Res; 1977; 16():65-70. PubMed ID: 269457
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunotherapy of cancer with BCG].
    Yamamura Y; Azuma I
    Nihon Rinsho; 1974 Mar; 32(3):542-53. PubMed ID: 4603604
    [No Abstract]   [Full Text] [Related]  

  • 34. [BCG immunotherapy in children with acute lymphocytic leukemia in continuous remission after 3 years of intensive chemotherapy (protocol C-70) (author's transl)].
    Ortega JJ; Javier G
    Med Clin (Barc); 1982 Mar 1-15; 78(5):183-8. PubMed ID: 6952060
    [No Abstract]   [Full Text] [Related]  

  • 35. [Trials of active immunotherapy in the treatment of acute lymphoid leukemia: influence of diverse factors on the results].
    Mathé G; Pouillart P; Schwarzenberg L
    Ann Med Interne (Paris); 1973 May; 124(5):443-8. PubMed ID: 4518979
    [No Abstract]   [Full Text] [Related]  

  • 36. Histocompatibility antigens (HLA) in acute lymphocytic leukemia.
    Ulukutlu L; Yazici H; Cam H; Esen E; Ozbakir F
    Turk J Pediatr; 1986; 28(2):111-4. PubMed ID: 3461609
    [No Abstract]   [Full Text] [Related]  

  • 37. [Considerations on some cases of acute lymphatic leukemia treated with aspecific active immunotheraphy].
    Saggese V; Zanda G
    Minerva Pediatr; 1974 Jun; 26(21):1087-93. PubMed ID: 4526571
    [No Abstract]   [Full Text] [Related]  

  • 38. HLA-A and HLA-B antigens in acute leukemia: A2--B12 phenotypes correlate with longer survival in acute myelogenous leukemia.
    von Fliedner VE; Sultan Khan Z; Jeannet M
    Acta Haematol; 1981; 65(2):73-8. PubMed ID: 6785965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotherapy in acute leukemias. Possible applications in children.
    Mahoney DH; Starling KA
    Am J Pediatr Hematol Oncol; 1981; 3(4):410-8. PubMed ID: 7036781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA haplotypes and long survival in childhood acute lymphoblastic leukaemia treated with transfer factor.
    De Bruyère M; Cornu G; Heremans-Bracke T; Malchaire J; Sokal G
    Br J Haematol; 1980 Feb; 44(2):243-51. PubMed ID: 6929700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.